These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 16013983

  • 1. New facets of androgen replacement therapy during childhood and adolescence.
    Rogol AD.
    Expert Opin Pharmacother; 2005 Jul; 6(8):1319-36. PubMed ID: 16013983
    [Abstract] [Full Text] [Related]

  • 2. Male pubertal development and the role of androgen therapy.
    Richmond EJ, Rogol AD.
    Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):338-44. PubMed ID: 17377616
    [Abstract] [Full Text] [Related]

  • 3. Pubertal androgen therapy in boys.
    Rogol AD.
    Pediatr Endocrinol Rev; 2005 Mar; 2(3):383-90. PubMed ID: 16429115
    [Abstract] [Full Text] [Related]

  • 4. Considerations for androgen therapy in children and adolescents with Klinefelter syndrome (47, XXY).
    Rogol AD, Tartaglia N.
    Pediatr Endocrinol Rev; 2010 Dec; 8 Suppl 1():145-50. PubMed ID: 21217606
    [Abstract] [Full Text] [Related]

  • 5. Use of testosterone gel compared to intramuscular formulation for puberty induction in males with constitutional delay of growth and puberty: a preliminary study.
    Chioma L, Papucci G, Fintini D, Cappa M.
    J Endocrinol Invest; 2018 Feb; 41(2):259-263. PubMed ID: 28695484
    [Abstract] [Full Text] [Related]

  • 6. Androgen Treatment in Adolescent Males With Hypogonadism.
    Rey RA, Grinspon RP.
    Am J Mens Health; 2020 Feb; 14(3):1557988320922443. PubMed ID: 32448030
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association between anthropometric hormonal measurements and bone mineral density in puberty and constitutional delay of growth and puberty.
    Doneray H, Orbak Z.
    West Indian Med J; 2010 Mar; 59(2):125-30. PubMed ID: 21275115
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibin B, AMH, but not INSL3, IGF1 or DHEAS support differentiation between constitutional delay of growth and puberty and hypogonadotropic hypogonadism.
    Rohayem J, Nieschlag E, Kliesch S, Zitzmann M.
    Andrology; 2015 Sep; 3(5):882-7. PubMed ID: 26266675
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of 451 Danish boys with delayed puberty: diagnostic use of a new puberty nomogram and effects of oral testosterone therapy.
    Lawaetz JG, Hagen CP, Mieritz MG, Blomberg Jensen M, Petersen JH, Juul A.
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1376-85. PubMed ID: 25594861
    [Abstract] [Full Text] [Related]

  • 12. Transition in endocrinology: induction of puberty.
    Dunkel L, Quinton R.
    Eur J Endocrinol; 2014 Jun; 170(6):R229-39. PubMed ID: 24836550
    [Abstract] [Full Text] [Related]

  • 13. Hypogonadism in Male Infants and Adolescents: New Androgen Formulations.
    Chioma L, Cappa M.
    Horm Res Paediatr; 2023 Jun; 96(6):581-589. PubMed ID: 34915486
    [Abstract] [Full Text] [Related]

  • 14. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty.
    Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):996-1001. PubMed ID: 8473416
    [Abstract] [Full Text] [Related]

  • 15. Androgen therapy in hypogonadal adolescent males.
    Bertelloni S, Baroncelli GI, Garofalo P, Cianfarani S.
    Horm Res Paediatr; 2010 Apr; 74(4):292-296. PubMed ID: 20938205
    [Abstract] [Full Text] [Related]

  • 16. Serum androgen bioactivity in adolescence: a longitudinal study of boys with constitutional delay of puberty.
    Raivio T, Dunkel L, Wickman S, Jänne OA.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1188-92. PubMed ID: 15001607
    [Abstract] [Full Text] [Related]

  • 17. Transdermal testosterone gel for induction and continuation of puberty in adolescent boys with hepatic dysfunction.
    Contreras MF, Raisingani M, Prasad K, Franklin B, Shah B.
    J Pediatr Endocrinol Metab; 2017 Jan 01; 30(1):105-109. PubMed ID: 27997352
    [Abstract] [Full Text] [Related]

  • 18. Testosterone Therapy in Adolescent Boys: The Need for a Structured Approach.
    Stancampiano MR, Lucas-Herald AK, Russo G, Rogol AD, Ahmed SF.
    Horm Res Paediatr; 2019 Jan 01; 92(4):215-228. PubMed ID: 31851967
    [Abstract] [Full Text] [Related]

  • 19. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major.
    Soliman AT, Nasr I, Thabet A, Rizk MM, El Matary W.
    Metabolism; 2005 Jan 01; 54(1):15-23. PubMed ID: 15562375
    [Abstract] [Full Text] [Related]

  • 20. Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy.
    Wood CL, Cheetham TD, Hollingsworth KG, Guglieri M, Ailins-Sahun Y, Punniyakodi S, Mayhew A, Straub V.
    BMC Pediatr; 2019 Apr 25; 19(1):131. PubMed ID: 31023296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.